JD secures 59.8% stake in German electronics retailer Ceconomy, with total control reaching 85.2% alongside partner Convergenta. The deal, pending regulatory approval, marks JD's strategic move into overseas markets.
Meesho will open its ₹42.5 billion IPO on December 3, comprising a fresh issue and an offer-for-sale of 105.5 million shares by existing investors. Proceeds will support infrastructure expansion, marketing, and strategic acquisitions, with pricing details to be announced separately.
5 days ago • India
Swiggy introduced a new ‘No Added Sugar’ category on its platform, aimed at helping health-conscious users make mindful food choices with ease. The category currently features over 1.5 lakh items from more than 50,000 restaurants across 10 major cities, with plans for expansion.
5 days ago • IndiaThe African Development Bank Group has approved a EUR 6.5 million commitment to the Saviu II venture capital fund to strengthen seed-stage technology financing in Francophone West and Central Africa. The investment, supported by the European Commission under Boost Africa, aims to accelerate digital entrepreneurship and regional market integration.
STRABAG’s subsidiary ZÜBLIN has secured two large-scale contracts from Codelco to advance the underground transformation of the Chuquicamata copper mine in Chile. The project includes more than 54 kilometres of tunnelling and critical infrastructure works, with completion targeted for 2031 and a workforce of around 1,200.
Mizoram has proposed a ₹174.7 billion budget for FY2026–27, with allocations focused on agriculture, connectivity and social infrastructure. The plan includes continued funding for farmer support programmes and supplementary grants of ₹37.24 billion for the current fiscal, reflecting a calibrated approach to fiscal management and development spending.
Blue Jet Healthcare will invest approximately ₹23 billion to establish a greenfield pharmaceutical manufacturing complex in Andhra Pradesh’s Rambilli Industrial Park. The phased project, expected to be operational by FY2028–29, will expand capacity for contrast media intermediates and specialty chemicals while creating 2,000 jobs.